40th ISOLS Orthopedic Oncology Webinar / February 17, 2026
Registration form will be available soon! DOWNLOAD FLYER
The purpose of the Association is to promote research, education and clinical practice related to musculoskeletal tumors and its foremost purpose is to improve patient care related to limb salvage interventions.
It also serves as a forum for intellectual exchange among physicians, engineers, scientists and other persons interested in limb salvage, promotes advances in the field of limb salvage and ongoing education of persons engaged in the field of limb salvage.
Registration form will be available soon! DOWNLOAD FLYER
Dear Colleagues, From time to Time all society’s need to review and update their own bylaws. This year we have seen extensive work to achieve
A Funeral for a Patient Reflections from Peter Steadman Recently, I had the honour of attending the funeral of a long-term sarcoma patient of mine.
ISOLS is proud to announce the recipients of our inaugural Travelling Research Fellowships: Dr Alexandra K. Callan from the United States and Dr Muhammad Phetrus
The ISOLS Engineering & Technology Committee (INSPIRE) held its second meeting to continue shaping how innovation in design, planning, and manufacturing will advance the future
Professor CLMH “Max” Gibbons 1957-2025 Professor CLMH “Max” Gibbons was appointed as a Consultant Orthopaedic Arthroplasty and Oncology Surgeon at the Nuffield Orthopaedic Centre, University
We have been made aware of spam and fraudulent messages circulating that falsely claim to come from ISOLS Board members.
Please note that official communications from ISOLS Board members will only ever be sent from the email address office@isols.com
Important: Fraudulent emails may display a familiar or trusted sender name on screen. Do not rely on the displayed name alone. Always check the full email address and its extension to confirm that it comes from the official @isols.com account.
Any messages claiming to be from Board members that come from other email addresses should be treated as suspicious and ignored. Do not click on links, open attachments, or provide any personal or financial information.
Thank you for your attention and cooperation in helping keep our community secure.
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information